Evidence map›Paper›PMID 42813074›Full record

ReviewJournal of multidisciplinary healthcare2026

Nuclear Medicine in IRAQ: From a Pioneering Past to Future Progress.

Ahmed Saad Abdlkadir, Mousa Al-Hissoni, Ibrahim Mohammed Hassan, Mohammed Naman Al-Adhami, Zuhair Al-Haydar, Adil Al-Nahhas, Raja'a Al-Attar, Amjed Al-Badr, Kamal Saleh Al-Hussaini, Mohamed Al-Shammaa and 8 more

Abstract readReview
In one paragraph

Review in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ahmed Saad AbdlkadirDepartment of Nuclear Medicine, Baghdad Radiotherapy and Nuclear Medicine Hospital, Baghdad, Iraq.ORCID 0000-0002-2009-5110
Mousa Al-HissoniIndependent Researcher, Baghdad, Iraq.
Ibrahim Mohammed HassanIndependent Researcher, Auckland, New Zealand.
Mohammed Naman Al-AdhamiIndependent Researcher, Toronto, ON, Canada.
Zuhair Al-HaydarIndependent Researcher, Toronto, ON, Canada.
Adil Al-NahhasPET/CT Centre, King's College London (KCL), London, United Kingdom.
Raja'a Al-AttarIndependent Researcher, Baghdad, Iraq.
Amjed Al-BadrDepartment of Nuclear Medicine, Al-Amal National Hospital for Oncology, Baghdad, Iraq.
Kamal Saleh Al-HussainiAl-Nokhba Medical Center, Wakra, Qatar.
Mohamed Al-ShammaaDepartment of Nuclear Medicine, Baghdad Radiotherapy and Nuclear Medicine Hospital, Baghdad, Iraq.
Rafid Riyadh Al-TumaDepartment of Nuclear Medicine, Al-Kawther Nuclear Medicine Center, Basra, Iraq.
Haider Al-AlawiDepartment of Nuclear Medicine, Amir Al-Momineen Specialty Hospital, Najaf, Iraq.
Aysar Najeh KhalafDepartment of Nuclear Medicine, Warith International Cancer Institute, Karbala, Iraq.
Farah M AnwarDepartment of Nuclear Medicine, Warith International Cancer Institute, Karbala, Iraq.
Qabas Swadi Al-RuwaishediDivision of Nuclear Medicine, Department of Medicine, Al-Yarmouk Teaching Hospital, Baghdad, Iraq.
Mustafa Al-ThabhaweeDepartment of Nuclear Medicine, Amal Al-Hayat Oncology Hospital, Najaf, Iraq.
Dhuha Al-AdhamiDepartment of Nuclear Medicine, Baghdad Radiotherapy and Nuclear Medicine Hospital, Baghdad, Iraq.
Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review article explores the trajectory of nuclear medicine in Iraq from its pioneering establishment in 1956 to its re-emergence as a cornerstone of precision medicine. The foundation of the Iraqi Atomic Energy Commission facilitated early regional training and domestic isotope production, fostering a self-sufficient clinical healthcare system. However, decades of conflict, sanctions, and isolation ensued in between 1980 and 2003 led to a profound systemic collapse and the erosion of both technical capacities and human resource continuity. Post-2003 reconstruction catalyzed a profound transformation, supported by national healthcare policy reforms, private investment, and international cooperation through the International Atomic Energy Agency. The integration of hybrid imaging technologies, radiotheranostics access, and structured specialist training programs marked the onset of sustainable recovery. Despite notable progress, significant disparities persist, including limited geographic equity, absence of unified national governance, and inadequate interdisciplinary recognition of nuclear medicine's theranostic potential by other specialties. The Iraqi experience thus underscores the interplay between political stability, science policy, and international collaboration as determinants of multidisciplinary healthcare modernization in post-conflict settings, offering key lessons for rebuilding specialized medical infrastructure under constrained conditions.

Indexed as

conflictsIRAQnuclear medicineradionuclide therapytheranostic challengestheranostics

Identifiers

PMID42813074
PMCPMC13621942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.